M. O. Atasoy Et Al. , "Development and evaluation of infectious laryngotracheitis virus-based recombinant vectored vaccine expressing Newcastle disease virus glycoproteins. ," 5th International Vaccine Science Congress , Kayseri, Turkey, pp.1-2, 2024
Atasoy, M. O. Et Al. 2024. Development and evaluation of infectious laryngotracheitis virus-based recombinant vectored vaccine expressing Newcastle disease virus glycoproteins. . 5th International Vaccine Science Congress , (Kayseri, Turkey), 1-2.
Atasoy, M. O., Vilela, J., Razzaq, S., Rohaim, M., & Munir, M., (2024). Development and evaluation of infectious laryngotracheitis virus-based recombinant vectored vaccine expressing Newcastle disease virus glycoproteins. . 5th International Vaccine Science Congress (pp.1-2). Kayseri, Turkey
Atasoy, MUSTAFA Et Al. "Development and evaluation of infectious laryngotracheitis virus-based recombinant vectored vaccine expressing Newcastle disease virus glycoproteins. ," 5th International Vaccine Science Congress, Kayseri, Turkey, 2024
Atasoy, MUSTAFA O. Et Al. "Development and evaluation of infectious laryngotracheitis virus-based recombinant vectored vaccine expressing Newcastle disease virus glycoproteins. ." 5th International Vaccine Science Congress , Kayseri, Turkey, pp.1-2, 2024
Atasoy, M. O. Et Al. (2024) . "Development and evaluation of infectious laryngotracheitis virus-based recombinant vectored vaccine expressing Newcastle disease virus glycoproteins. ." 5th International Vaccine Science Congress , Kayseri, Turkey, pp.1-2.
@conferencepaper{conferencepaper, author={MUSTAFA OZAN ATASOY Et Al. }, title={Development and evaluation of infectious laryngotracheitis virus-based recombinant vectored vaccine expressing Newcastle disease virus glycoproteins. }, congress name={5th International Vaccine Science Congress}, city={Kayseri}, country={Turkey}, year={2024}, pages={1-2} }